Cécile Ged Selected Research

Erythropoietic Porphyria (Congenital Erythropoietic Porphyria)

1/2024	Severe Perinatal Presentations of Günther's Disease: Series of 20 Cases and Perspectives.
6/2021	Identification of novel UROS mutations in a patient with congenital erythropoietic porphyria and efficient treatment by phlebotomy.
11/2020	Iron chelation rescues hemolytic anemia and skin photosensitivity in congenital erythropoietic porphyria.
1/2020	Bone Marrow Transplantation in Congenital Erythropoietic Porphyria: Sustained Efficacy but Unexpected Liver Dysfunction.
12/2019	Genetic background influences hepcidin response to iron imbalance in a mouse model of hemolytic anemia (Congenital erythropoietic porphyria).
1/2019	CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations.
1/2017	Missense UROS mutations causing congenital erythropoietic porphyria reduce UROS homeostasis that can be rescued by proteasome inhibition.
1/2017	Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.
11/2013	Therapeutic potential of proteasome inhibitors in congenital erythropoietic porphyria.
7/2012	Metabolic correction of congenital erythropoietic porphyria with iPSCs free of reprogramming factors.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cécile Ged Research Topics

Disease

15	Erythropoietic Porphyria (Congenital Erythropoietic Porphyria) 01/2024 - 02/2005
6	Hemolytic Anemia 11/2020 - 07/2012
5	Anemia 11/2022 - 01/2017
5	Iron Overload 11/2020 - 05/2012
4	Porphyrias (Porphyria) 01/2024 - 07/2002
4	Hemolysis 11/2020 - 01/2017
2	Xeroderma Pigmentosum (Kaposi's Disease) 01/2022 - 01/2020
2	Liver Failure 01/2020 - 06/2008
2	Colorectal Neoplasms (Colorectal Cancer) 06/2015 - 06/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2022
1	Hypercholesterolemia 05/2022
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 05/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 05/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Rare Diseases (Rare Disease) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Liver Diseases (Liver Disease) 01/2020
1	Congenital Hemolytic Anemia (Hemolytic Anemia, Congenital) 12/2019
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2019
1	Hyperferritinemia 11/2018
1	Hematologic Diseases (Blood Diseases) 01/2017
1	Homocystinuria 01/2015
1	Thrombophilia 01/2015
1	type 4 Hemochromatosis 09/2014
1	Neoplasms (Cancer) 06/2014
1	Hemochromatosis (Bronze Diabetes) 05/2012
1	Inflammation (Inflammations) 12/2011
1	Atrophy 12/2011
1	Ichthyosis Vulgaris (Dominant Ichthyosis Vulgaris) 01/2007
1	Infections 01/2007
1	Asthma (Bronchial Asthma) 01/2007
1	Atopic Dermatitis (Atopic Eczema) 01/2007
1	Erythropoietic Protoporphyria 09/2003
1	Hepatitis 01/2003
1	Porphyria Cutanea Tarda 07/2002
1	Hepatoerythropoietic Porphyria 07/2002

Drug/Important Bio-Agent (IBA)

10	Uroporphyrinogen III Synthetase (Uroporphyrinogen-III Synthase)IBA 01/2024 - 01/2008
9	Heme (Haem)IBA 01/2024 - 09/2003
9	PorphyrinsIBA 06/2021 - 07/2002
7	EnzymesIBA 01/2024 - 09/2003
4	IronIBA 11/2020 - 09/2014
2	Hemoglobins (Hemoglobin)IBA 11/2022 - 01/2017
2	HepcidinsIBA 12/2019 - 01/2017
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2019 - 01/2019
2	Transferrin (beta 2 Transferrin)IBA 11/2018 - 05/2012
2	Proteasome InhibitorsIBA 01/2017 - 11/2013
2	Irinotecan (Camptosar)FDA LinkGeneric 06/2015 - 06/2014
1	hemoglobin AgrinioIBA 11/2022
1	oxidized low density lipoproteinIBA 05/2022
1	LDL CholesterolIBA 05/2022
1	pembrolizumabIBA 01/2022
1	Ferritins (Ferritin)IBA 06/2021
1	DeferiproneIBA 11/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Transaminases (Aminotransferases)IBA 01/2020
1	HemopexinIBA 01/2017
1	HaptoglobinsIBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Heme Oxygenase-1IBA 01/2017
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2017
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2017
1	CystathionineIBA 01/2015
1	metal transporting protein 1 (ferroportin)IBA 09/2014
1	Carrier Proteins (Binding Protein)IBA 09/2014
1	Cytotoxins (Cytolysins)IBA 06/2014
1	IntegrinsIBA 12/2011
1	Immunoglobulin E (IgE)IBA 01/2007
1	Phosphoglycerate Kinase (Kinase, Phosphoglycerate)IBA 01/2007
1	Alkylating AgentsIBA 01/2007
1	Filaggrin ProteinsIBA 01/2007
1	protoporphyrin IXIBA 09/2003
1	Ferrochelatase (Heme Synthetase)IBA 09/2003
1	Peptide Elongation Factors (Elongation Factor)IBA 01/2003
1	ElementsIBA 01/2003
1	enhanced green fluorescent proteinIBA 01/2003
1	Glutamic Acid (Glutamate)FDA Link 07/2002
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 07/2002
1	Codon (Codons)IBA 07/2002

Therapy/Procedure

4	Therapeutics 06/2015 - 02/2005
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2020 - 02/2005
1	Liver Transplantation 06/2008
1	Stem Cell Transplantation 02/2005